ADVERTISEMENT

Igm Biosciences Contact Us

WebJan 3, 2024 · IGM Biosciences Announces Retirement of Chairman Michael Loberg, Ph.D. from Board of Directors and Appointment of Elizabeth H.Z. Thompson, Ph.D. to Board of …

See Also: Home Phone PreviewShow details

ADVERTISEMENT

WebWe have overcome various challenges to create these “super antibodies” and we intend to continue exploring new scientific boundaries and identifying how this new type of …

Estimated Reading Time: 1 min

See Also: Phone Number PreviewShow details

WebPrimary 325 E Middlefield Rd Mountain View, California 94043, US Get directions Employees at IGM Biosciences, Inc.

See Also: Phone Number PreviewShow details

(650) 965-7873

WebNov 19, 2023 · (650) 965-7873 Website www.igmbio.com Revenue $40.6 Million Stock Symbol IGMS Industry Business Services General Business Services Recent News & …

See Also: Business PreviewShow details

WebDetails Industries Biotechnology Medical Therapeutics Headquarters Regions San Francisco Bay Area, Silicon Valley, West Coast Founded Date 2010 Founders Nelson Teng Operating Status Active Last Funding Type …

See Also: Tech Support PreviewShow details

ADVERTISEMENT

WebMar 29, 2005 · Fred Schwarzer Chief Executive Officer of IGM Biosciences “ Sanofi is a global leader in the development and commercialization of innovative therapies, and we …

See Also: Office PreviewShow details

WebOct 16, 2020 · Pioneering the development of engineered IgM antibodies. Page · Biotechnology Company. 325 East Middlefield Rd, Mountain View, CA, United States, …

See Also: Tech Support PreviewShow details

WebDec 29, 2023 · Misbah Tahir, Chief Financial Officer Suzette Tauber, Chief Human Resources Officer and 1 others Operating Metrics View all

See Also: Office PreviewShow details

WebJan 12, 2021 · The combination of IGM-8444, an IgM antibody targeting Death Receptor 5 (DR5) being developed by IGM, and birinapant has been shown to enhance anti-tumor …

See Also: Phone Number PreviewShow details

WebDec 5, 2023 · IGM Biosciences, Inc. – Priorities: clinical development of DR5 agonist in colorectal cancer and T cell engagers in autoimmune disease –. – Plans to file IND for …

See Also: Cell Phone PreviewShow details

WebFeb 2, 2022 · John George reported the eastbound moving vans for the Philadelphia Business Journal. IGM is relocating two business units to the Pennsylvania …

See Also: Business PreviewShow details

WebMisbah Tahir Chief Financial Officer Chris H. Takimoto, M.D., Ph.D., F.A.C.P. Chief Medical Officer Suzette Tauber Chief Human Resources Officer Steven Weber Senior Vice …

See Also: Medical PreviewShow details

WebNov 7, 2023 · Jan 3, 2024 IGM Biosciences to Present at the 42nd Annual J.P. Morgan Healthcare Conference Dec 5, 2023 IGM Biosciences Announces Strategic Pipeline …

See Also: Health PreviewShow details

ADVERTISEMENT

Web201 to 500 Employees. 1 Location. Type: Company - Public (IGMS) Founded in 2010. Revenue: Unknown / Non-Applicable. Biotechnology. Competitors: Unknown. About IGM

See Also: Tech Support PreviewShow details

WebJan 2, 2024 · IGM Biosciences has an overall rating of 4.2 out of 5, based on over 19 reviews left anonymously by employees. 66% of employees would recommend working …

See Also: Phone Number PreviewShow details

WebJun 22, 2023 · Concurrent with the public offering, IGM intends to sell, subject to the consummation of the public offering and other customary conditions, in a private …

See Also: Phone Number PreviewShow details

WebMar 29, 2022 · MOUNTAIN VIEW, Calif., March 29, 2022 (GLOBE NEWSWIRE) -- IGM Biosciences, Inc. (NASDAQ: IGMS) today announced that it intends to offer and sell …

See Also: Phone Number PreviewShow details

Please leave your comments here:

 
ADVERTISEMENT
ADVERTISEMENT

ADVERTISEMENT

Popular Search